Cargando...
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
Chimeric antigen receptor (CAR) T cell therapies have demonstrated remarkable efficacy for the treatment of hematological malignancies. However, in patients with solid tumors, objective responses to CAR-T cell therapy remain sporadic and transient. A major obstacle for CAR-T cells is the intrinsic a...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7311654/ https://ncbi.nlm.nih.gov/pubmed/32625204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01109 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|